122 related articles for article (PubMed ID: 7947629)
1. [Lesions of the pancreatic duct epithelium and histogenesis of exocrine pancreatic carcinomas].
Schulz HJ
Zentralbl Pathol; 1994 Aug; 140(3):203-10. PubMed ID: 7947629
[TBL] [Abstract][Full Text] [Related]
2. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
3. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
4. AgNORs in duct epithelial lesions in chronic pancreatitis and in pancreas cancer cells.
Cylwik B; Nowak HF; Puchalski Z; Zimnoch L; Dadan J
Hepatogastroenterology; 1998; 45(22):1130-4. PubMed ID: 9756019
[TBL] [Abstract][Full Text] [Related]
5. Histogenesis of pancreatic carcinomas: a study based on 248 cases.
Chen J; Baithun SI; Ramsay MA
J Pathol; 1985 May; 146(1):65-76. PubMed ID: 4009323
[TBL] [Abstract][Full Text] [Related]
6. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
7. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
8. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
[TBL] [Abstract][Full Text] [Related]
9. [Histomorphometric study of normal, atypical and neoplastic pancreatic duct epithelium].
von Streitberg U
Verh Dtsch Ges Pathol; 1990; 74():207-10. PubMed ID: 1708585
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional structure of the rat pancreatic duct in normal and inflammated pancreas.
Ashizawa N; Endoh H; Hidaka K; Watanabe M; Fukumoto S
Microsc Res Tech; 1997 Jun 1-15; 37(5-6):543-56. PubMed ID: 9220430
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
[TBL] [Abstract][Full Text] [Related]
13. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
[TBL] [Abstract][Full Text] [Related]
14. [Histogenetic classification of exocrine pancreatic carcinomas].
Schulz HJ
Zentralbl Allg Pathol; 1989; 135(4):339-49. PubMed ID: 2781881
[TBL] [Abstract][Full Text] [Related]
15. The pancreas. Nonneoplastic alterations.
Oertel JE
Am J Surg Pathol; 1989; 13 Suppl 1():50-65. PubMed ID: 2699169
[TBL] [Abstract][Full Text] [Related]
16. Endocrine and intermediate cells in pancreatic ductal carcinoma and in chronic pancreatitis.
Szynaka B; Zimnoch L; Puchalski Z; Szynaka P
Rocz Akad Med Bialymst; 2002; 47():21-30. PubMed ID: 12533945
[TBL] [Abstract][Full Text] [Related]
17. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
18. Proposal for the classification of epithelial atypism of pancreatic duct lesions.
Kimura W
Hepatogastroenterology; 2007; 54(79):2155-8. PubMed ID: 18251180
[TBL] [Abstract][Full Text] [Related]
19. HER-2/Neu expression as a progression marker in pancreatic intraepithelial neoplasia.
Tomaszewska R; Okoń K; Nowak K; Stachura J
Pol J Pathol; 1998; 49(2):83-92. PubMed ID: 9798411
[TBL] [Abstract][Full Text] [Related]
20. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
